Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma

REFERENCES

• Abe, N., T. Watanabe, M. Sugiyama, H. Uchimura, G. Chiappetta, A. Fusco, and Y. Atomi. 1999. Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker. Cancer Res. 59: 1169–1174.
   PubMedGoogle Scholar
• Abe, N., T. Watanabe, T. Masaki, T. Mori, M. Sugiyama, H. Uchimura, Y. Fujioka, G. Chiappetta, A. Fusco, and Y. Atomi. 2000. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. Cancer Res. 60: 3117–3122.
   PubMedGoogle Scholar
• Baldassarre, G., M. V. Barone, B. Belletti, C. Sandomenico, P. Bruni, S. Spiezia, A. Boccia, M. T. Vento, A. Romano, S. Pepe, A. Fusco, and G. Viglietto. 1999. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. Oncogene 18: 6241–6251.
   PubMedGoogle Scholar
• Baldassarre, G., M. Fedele, S. Battista, A. Vecchione, A. J. Klein-Szanto, M. Santoro, T. A. Waldmann, N. Azimi, C. M. Croce, and A. Fusco. 2001. Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc. Natl. Acad. Sci. USA 98: 7970–7975.
   PubMed Web of Science ®Google Scholar
• Bandiera, A., D. Bonifacio, G. Manfioletti, F. Mantovani, A. Rustighi, F. Zanconati, A. Fusco, L. Di Bonito, and V. Giancotti. 1998. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res. 58: 426–431.
   PubMed Web of Science ®Google Scholar
• Berlingieri, M. T., G. Manfioletti, M. Santoro, A. Bandiera, R. Visconti, V. Giancotti, and A. Fusco. 1995. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol. Cell. Biol. 15: 1545–1553.
   PubMed Web of Science ®Google Scholar
• Bernard-Gallon, D. J., M. P. De Latour, P. G. Rio, F. M. Penault-Llorca, D. A. Favy, C. Hizel, J. Chassagne, and Y. J. Bignon. 1999. Subcellular localization of BRCA1 protein in sporadic breast carcinoma with or without allelic loss of BRCA1 gene. Int. J. Oncol. 14: 653–661.
   PubMedGoogle Scholar
• Bennett, L. M., H. A. Brownlee, S. Hagavik, and R. W. Wiseman. 1999. Sequence analysis of the rat Brca1 homolog and its promoter region. Mamm. Genome 10: 19–25.
   PubMedGoogle Scholar
• Bianco, T., G. Chenevix-Trench, D. C. Walsh, J. E. Cooper, and A. Dobrovic. 2000. Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis 21: 147–151.
   PubMedGoogle Scholar
• Braunstein, M., A. B. Rose, S. G. Holmes, C. D. Allis, and J. R. Broach. 1993. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev. 7: 592–604.
   PubMed Web of Science ®Google Scholar
• Catteau, A., W. H. Harris, C. F. Xu, and E. Solomon. 1999. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18: 1957–1965.
   PubMed Web of Science ®Google Scholar
• Chiappetta, G., V. Avantaggiato, R. Visconti, M. Fedele, S. Battista, F. Trapasso, B. M. Merciai, V. Fidanza, V. Giancotti, M. Santoro, A. Simeone, A. Fusco. 1996. High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13: 2439–2446.
   PubMed Web of Science ®Google Scholar
• Chiappetta, G., G. Tallini, M. C. De Biasio, G. Manfioletti, F. J. Martinez-Tello, F. Pentimalli, F. de Nigris, A. Mastro, G. Botti, M. Fedele, N. Berger, M. Santoro, V. Giancotti, and A. Fusco. 1998. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res. 58: 4193–4198.
   PubMedGoogle Scholar
• Chiappetta, G., G. Manfioletti, F. Pentimalli, N. Abe, M. Di Bonito, M. T. Vento, A. Giuliano, M. Fedele, G. Viglietto, M. Santoro, T. Watanabe, V. Giancotti, and A. Fusco. 2001. High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases. Int. J. Cancer. 91: 147–151.
   PubMed Web of Science ®Google Scholar
• Chiappetta, G., A. Bandiera, M. T. Berlingieri, R. Visconti, G. Manfioletti, S. Battista, F. J. Martinez-Tello, M. Santoro, V. Giancotti, and A. Fusco. 1995. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 10: 1307–1314.
   PubMed Web of Science ®Google Scholar
• Dobrovic, A., and D. Simpfendorfer. 1997. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 57: 3347–3350.
   PubMed Web of Science ®Google Scholar
• Fan, S., J. Wang, R. Yuan, Y. Ma, Q. Meng, M. R. Erdos, R. G. Pestell, F. Yuan, K. J. Auborn, I. D. Goldberg, and E. M. Rosen. 1999. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284: 1354–1356.
   PubMed Web of Science ®Google Scholar
• Fan, S., Y. X. Ma, C. Wang, R. Q. Yuan, Q. Meng, J. A. Wang, M. Erdos, I. D. Goldberg, P. Webb, P. J. Kushner, R. G. Pestell, and E. M. Rosen. 2001. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 20: 77–87.
   PubMed Web of Science ®Google Scholar
• Fedele, M., A. Bandiera, G. Chiappetta, S. Battista, G. Viglietto, G. Manfioletti, A. Casamassimi, M. Santoro, V. Giancotti, and A. Fusco. 1996. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res. 56: 1896–1901.
   PubMedGoogle Scholar
• Fedele, M., G. M. Pierantoni, M. T. Berlingieri, S. Battista, G. Baldassarre, N. Munshi, M. Dentice, D. Thanos, M. Santoro, G. Viglietto, and A. Fusco. 2001. Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells. Cancer Res. 61: 4583–4590.
   PubMed Web of Science ®Google Scholar
• Futreal, P. A., Q. Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L. M. Bennett, A. Haugen-Strano, J. Swensen, Y. Miki, et al. 1994. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120–122.
   PubMed Web of Science ®Google Scholar
• Gudas, J. M., H. Nguyen, T. Li., and K. H. Cowan. 1995. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res. 55: 4561–4565.
   PubMed Web of Science ®Google Scholar
• Gudas, J. M., T. Li, H. Nguyen, D. Jensen, F. J. Rauscher, and K. H. Cowan. 1996. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ. 7: 717–723.
   PubMedGoogle Scholar
• Hartman, A. R., and J. M. Ford. 2002. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat. Gen. 32: 180-184.
   PubMed Web of Science ®Google Scholar
• Hilakivi-Clarke, L. 2000. Estrogens, BRCA1, and breast cancer. Cancer Res. 60: 4993–5001.
   PubMed Web of Science ®Google Scholar
• Jarvis, E. M., J. A. Kirk, and C. L. Clarke. 1998. Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype. Cancer Genet. Cytogenet. 101: 109–115.
   PubMedGoogle Scholar
• Kinzler, K., and B. Vogelstein. 1997. Gatekeepers and caretakers. Nature 386: 761–763.
   PubMed Web of Science ®Google Scholar
• Liu, W. M., F. K. Guerra-Vladusic, S. Kurakata, R. Lupu, and T. Kohwi-Shigematsu. 1999. HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype. Cancer Res. 59: 5695–5703.
   PubMedGoogle Scholar
• Magdinier, F., S. Ribieras, G. M. Lenoir, L. Frappart, and R. Dante. 1998. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene 17: 3169–3176.
   PubMedGoogle Scholar
• Marquis, S. T., J. V. Rajan, A. Wynshaw-Boris, J. Xu, G. Y. Yin, K. J. Abel, B. L. Weber, and L. A. Chodosh. 1995. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat. Genet. 11: 17–26.
   PubMed Web of Science ®Google Scholar
• Miki, Y., J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L. M. Bennett, W. Ding, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.
   PubMed Web of Science ®Google Scholar
• Orlando, V. 2000. Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. Trends Biochem. Sci. 25: 99–104.
   PubMed Web of Science ®Google Scholar
• Ram, T. G., R. Reeves, and H. L. Hosick. 1993. Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res. 53: 2655–2660.
   PubMed Web of Science ®Google Scholar
• Reeves, R., D. D. Edberg, and Y. Li. 2001. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell. Biol. 21: 575–594.
   PubMed Web of Science ®Google Scholar
• Reeves, R., and L. Beckerbauer. 2001. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim. Biophys. Acta 1519: 13–29.
   PubMed Web of Science ®Google Scholar
• Rice, J. C., H. Ozcelik, P. Maxeiner, I. Andrulis, and B. W. Futscher. 2000. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21: 1761–1765.
   PubMed Web of Science ®Google Scholar
• Rio, P. G., J. C. Maurizis, M. Peffault de Latour, Y. J. Bignon, and D. J. Bernard-Gallon. 1999. Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene. Int. J. Cancer 80: 823–826.
   PubMed Web of Science ®Google Scholar
• Romagnolo, D., L. A. Annab, T. E. Thompson, J. I. Risinger, L. A. Terry, J. C. Barrett, and C. A. Afshari. 1998. Estrogen upregulation of BRCA1 expression with no effect on localization. Mol. Carcinog. 22: 102–109.
   PubMedGoogle Scholar
• Ruffner, H., and I. M. Verma. 1997. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. Natl. Acad. Sci. USA 94: 7138–7143.
   PubMed Web of Science ®Google Scholar
• Russell, P. A., P. D. Pharoah, K. De Foy, S. J. Ramus, I. Symmonds, A. Wilson, I. Scott, B. A. Ponder, and S. A. Gayther. 2000. Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers. Int. J. Cancer 87: 317–321.
   PubMedGoogle Scholar
• Scala, S., G. Portella, M. Fedele, G. Chiappetta, and A. Fusco. 2000. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc. Natl. Acad. Sci. USA 97: 4256–4261.
   PubMed Web of Science ®Google Scholar
• Schafer, J. M., E. S. Lee, R. M. O'Regan, K. Yao, and V. C. Jordan. 2000. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice. Clin. Cancer Res. 6: 4373–4380.
   PubMed Web of Science ®Google Scholar
• Scully, R., and D. L. Livingston. 2000. In search of the tumor suppressor function of BRCA1 and BRCA2. Nature 408: 429–432.
   PubMed Web of Science ®Google Scholar
• Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteoporosis in mice. Cell 64: 693–702.
   PubMed Web of Science ®Google Scholar
• Sourvinos, G., and D. A. Spandidos. 1998. Decreased BRCA1 expression may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Biochem. Biophys. Res. Comm. 245: 75–80.
   PubMedGoogle Scholar
• Tamimi, Y., H. G. van der Poel, M. M. Denyn, R. Umbas, H. F. Karthaus, F. M. Debruyne, and J. A. Schalken. 1993. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res. 3: 5512–5516.
   Google Scholar
• Thakur, S., H. B. Zhang, Y. Peng, H. Le, B. Carroll, T. Ward, J. Yao, L. M. Farid, F. J. Couch, R. B. Wilson, and B. L. Weber. 1997. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol. 17: 444–452.
   PubMed Web of Science ®Google Scholar
• Thakur, S., and C. M. Croce. 1999. Positive regulation of the BRCA1 promoter. J. Biol. Chem. 274: 8837–8843.
   PubMedGoogle Scholar
• Thompson, M. E., R. A. Jensen, P. S. Obermiller, D. L. Page, and J. T. Holt. 1995. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet. 9: 444–450.
   PubMed Web of Science ®Google Scholar
• Vaughn, J. P., P. L. Davis, M. D. Jarboe, G. Huper, A. C. Evans, R. W. Wiseman, A. Berchuck, J. D. Iglehart P. A. Futreal, and J. R. Marks. 1996. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ. 7: 711–715.
   PubMedGoogle Scholar
• Wilson, C. A., L. Ramos, M. R. Villaseñor, K. H. Anders, M. F. Press, K. Clarke, B. Karlan, J. J. Chen, R. Scully, D. Livingston, R. H. Zuch, M. H. Kanter, S. Cohen, F. J. Calzone, and D. J. Slamon. 1999. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat. Gen. 21: 236–240.
   PubMed Web of Science ®Google Scholar
• Yoshikawa, K., K. Honda, T. Inamoto, H. Shinohara, A. Yamauchi, K. Suga, T. Okuyama, T. Shimada, H. Kodama, S. Noguchi, A. F. Gazdar, Y. Yamaoka, and R. Takahashi. 1999. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss inBRCA1-associated cases. Clin. Cancer Res. 5: 1249–1261.
   PubMedGoogle Scholar
• Zhou, X., K. F. Benson, H. R. Ashar, and K. Chada. 1995. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376: 771–774.
   PubMed Web of Science ®Google Scholar